Bellerophon Therapeutics, Inc.
BLPHDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001600132
Bellerophon Therapeutics, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Oct 16, 2023; 22 institutions reported holding it in 13F filings for Q3 2023, worth $506.6K in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Bellerophon Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +4 vs. Q1 2023
- Shares held
- 1.20M
- −2.34M (−66.1%) vs. Q1 2023
- Total value
- $824.9K
- −$27.1M (−97.0%) vs. Q1 2023
- New holders
- 11
- 6 more added
- Sold out
- 7
- 2 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BLPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 2 | $6.37K |
| Q3 2023 | 22 | $506.6K |
| Q2 2023 | 23 | $824.9K |
| Q1 2023 | 19 | $27.9M |
| Q4 2022 | 25 | $832.7K |
| Q3 2022 | 19 | $1.18M |
| Q2 2022 | 19 | $1.40M |
| Q1 2022 | 22 | $2.68M |
| Q4 2021 | 22 | $3.82M |
| Q3 2021 | 22 | $4.81M |
| Q2 2021 | 27 | $6.34M |
| Q1 2021 | 39 | $10.9M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Bellerophon Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Acadian Asset Management LLC | 265,253 | $182.0K | 0.00% | +265,253 | New |
| Wells Fargo & Company | 200,075 | $138.1K | 0.00% | +90.0% | Added |
| Vanguard Group Inc | 145,810 | $100.6K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 129,876 | $89.6K | 0.00% | +33,527+34.8% | Added |
| Two Sigma Investments, LP | 103,787 | $71.6K | 0.00% | +103,787 | New |
| Geode Capital Management, LLC | 95,656 | $66.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 77,299 | $53.0K | 0.00% | −92,600−54.5% | Reduced |
| Northern Trust Corp | 38,221 | $26.4K | 0.00% | +8,086+26.8% | Added |
| Advisor Group Holdings, Inc. | 30,614 | $21.1K | 0.00% | +29,614+2,961.4% | Added |
| State Street Corp | 30,127 | $20.8K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 25,870 | $18.0K | 0.00% | +25,870 | New |
| Two Sigma Advisers, LP | 14,900 | $10.3K | 0.00% | +14,900 | New |
| Raymond James & Associates | 11,097 | $7.66K | 0.00% | +11,097 | New |
| Two Sigma Securities, LLC | 10,355 | $7.14K | 0.00% | +10,355 | New |
| Tower Research Capital LLC (TRC) | 7,150 | $4.93K | 0.00% | +6,664+1,371.2% | Added |
| PFS Partners, LLC | 6,000 | $4.14K | 0.00% | +6,000 | New |
| Group One Trading, L.P. | 3,900 | $2.69K | 0.00% | +3,900 | New |
| US Bancorp | 1,221 | $842 | 0.00% | 00.0% | Unchanged |
| GPS Wealth Strategies Group, LLC | 38 | $27 | 0.00% | +38 | New |
| Morgan Stanley | 33 | $23 | 0.00% | −901,434−100.0% | Reduced |
| Royal Bank of Canada | 192 | $0 | 0.00% | +180+1,500.0% | Added |
| Simplex Trading, LLC | 95 | $0 | 0.00% | +95 | New |
| Sofos Investments, Inc. | 1 | – | – | +1 | New |
| Proequities, Inc. | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −930,000−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −893,974−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −13,585−100.0% | Sold out |
| NTV Asset Management LLC | 0 | $0 | 0.00% | −12,950−100.0% | Sold out |
| Destination Wealth Management | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −500−100.0% | Sold out |